Association/NN
of/IN
Common/JJ
Vitamin/NN
D/NN
Receptor/NN
Gene/NN
Variations/NNS
with/IN
Fracture/NN
Risk/NN
and/CC
Bone/NN
Mineral/JJ
Density/NN
in/IN
Postmenopausal/JJ
Korean/JJ
Population/NN
./.
====================
Osteoporosis/NN
is/VBZ
characterized/VBN
by/IN
impaired/JJ
osteogenesis/NN
./.
====================
BMD/NN
is/VBZ
a/DT
major/JJ
determinant/NN
of/IN
bone/NN
strength/NN
./.
====================
The/DT
role/NN
of/IN
the/DT
VDR/NN
gene/NN
in/IN
predisposition/NN
to/TO
primary/JJ
osteoporosis/NN
has/VBZ
been/VBN
recognized/VBN
./.
====================
However/RB
,/,
populationbased/VBD
case-control/JJ
studies/NNS
have/VBP
been/VBN
reported/VBN
controversial/JJ
results/VBZ
for/IN
known/VBN
candidate/NN
genes/NNS
in/IN
an/DT
ethnically/RB
distinct/JJ
group/NN
./.
====================
To/TO
determine/VB
the/DT
genetic/JJ
effects/NNS
of/IN
VDR/NN
variants/NNS
on/IN
osteoporosis/NN
and/CC
BMD/NN
,/,
we/PRP
directly/RB
sequenced/VBN
the/DT
VDR/NN
gene/NN
in/IN
24/CD
unrelated/JJ
Korean/JJ
individuals/NNS
and/CC
identified/VBD
eighteen/CD
sequence/NN
variants/NNS
./.
====================
We/PRP
investigated/VBD
the/DT
potential/JJ
involvement/NN
of/IN
eight/CD
SNPs/NNS
in/IN
osteoporosis/NN
in/IN
postmenopausal/JJ
women/NNS
(/(
n/NN
=/JJ
729/CD
)/)
./.
====================
Two/CD
SNPs/NNS
(/(
LD/NN
)/)
in/IN
intron/NN
2/CD
,/,
−5294G＞C/NN
(/(
rs2238135/NN
)/)
and/CC
−4817G＞A/NN
(/(
rs17882443/NN
)/)
showed/VBD
the/DT
evidence/NN
of/IN
association/NN
with/IN
enhanced/VBN
BMD/NN
of/IN
the/DT
femoral/JJ
neck/NN
(/(
padditive=0.031/NN
for/IN
rs2238135/NN
;/:
padditive=0.017/RB
and/CC
pdominant=/JJ
0.019/CD
for/IN
17882443/CD
)/)
./.
====================
Moreover/RB
,/,
VDR/NN
−4817G＞A/NN
was/VBD
significantly/RB
associated/VBN
with/IN
protective/JJ
effect/NN
on/IN
all/DT
fracture/NN
risk/NN
(/(
precessive=0.035/NN
,/,
OR=0.2/CD
,/,
95/CD
%/NN
CI=0.05∼0.89/NN
)/)
,/,
and/CC
tended/VBD
to/TO
be/VB
higher/JJR
BMD/NN
values/NNS
at/IN
various/JJ
proximal/JJ
femur/JJ
sites/NNS
./.
====================
Therefore/RB
,/,
we/PRP
suggest/VBP
that/IN
the/DT
−4817G＞A/NN
may/MD
be/VB
useful/JJ
genetic/JJ
marker/NN
for/IN
vitamin/NN
Drelated/JJ
metabolism/NN
and/CC
may/MD
have/VB
an/DT
important/JJ
role/NN
in/IN
the/DT
increased/VBN
BMD/NN
of/IN
the/DT
proximal/JJ
femur/JJ
in/IN
postmenopausal/JJ
Korean/JJ
women/NNS
./.
====================
Osteoporosis/NN
is/VBZ
called/VBN
“/NN
the/DT
silent/JJ
bone/NN
disease/NN
”/CD
,/,
characterized/VBN
by/IN
compromised/VBN
bone/NN
strength/NN
,/,
predisposes/VBZ
individuals/NNS
to/TO
increased/VBN
risk/NN
of/IN
fracture/NN
,/,
especially/RB
of/IN
the/DT
hip/NN
and/CC
vertebra/RB
in/IN
postmenopausal/JJ
women/NNS
(/(
Eisman/JJ
,/,
1999/CD
;/:
Hwang/NNP
et/FW
al./FW
,/,
2006/CD
)/)
./.
====================
Bone/DT
loss/NN
from/IN
an/DT
imbalanced/JJ
remodeling/NN
between/IN
osteoclastic/JJ
resorption/NN
and/CC
osteoblastic/JJ
formation/NN
is/VBZ
observed/VBN
at/IN
the/DT
time/NN
of/IN
menopause/JJ
,/,
mainly/RB
due/JJ
to/TO
estrogen/NN
deficiency/NN
and/CC
calciotropic/JJ
hormone/NN
insufficiency/NN
such/JJ
as/IN
vitamin/NN
D/NN
(/(
Boyle/NNP
et/FW
al./FW
,/,
2003/CD
;/:
Harada/NNP
&/CC
Rodan/NNP
,/,
2003/CD
;/:
Khosla/NNP
,/,
2001/CD
)/)
./.
====================
Vitamin/NN
D/NN
effects/NNS
on/IN
bone/NN
are/VBP
mediated/VBN
through/IN
the/DT
vitamin/NN
D/NN
receptor/NN
(/(
VDR/NN
)/)
,/,
a/DT
nuclear/JJ
transcription/NN
factor/NN
that/WDT
regulates/VBZ
bone/NN
formation/NN
,/,
bone/NN
resorption/NN
,/,
and/CC
calcium/NN
homeostasis/NN
by/IN
interacting/VBG
with/IN
vitamin/NN
D/NN
response/NN
elements/NNS
(/(
VDREs/NNS
)/)
within/IN
Vitamin/NN
D/NN
target/NN
genes/NNS
./.
====================
Allelic/JJ
variation/NN
in/IN
the/DT
VDR/NN
gene/NN
explains/VBZ
75/CD
%/NN
of/IN
the/DT
genetic/JJ
variability/NN
in/IN
BMD/NN
used/VBN
as/IN
a/DT
proxy/JJ
measure/VB
(/(
Eisman/JJ
,/,
1999/CD
;/:
Liu/NNP
et/FW
al./FW
,/,
2003/CD
;/:
Morrison/NNP
et/FW
al./FW
,/,
1994/CD
)/)
./.
====================
Since/IN
the/DT
first/JJ
association/NN
by/IN
Morrison/NNP
et/FW
al./FW
,/,
allelic/JJ
variations/NNS
in/IN
genetic/JJ
regulation/NN
of/IN
BMD/NN
have/VBP
been/VBN
subsequently/RB
studied/VBN
in/IN
candidate/NN
genes/NNS
related/JJ
to/TO
important/JJ
elements/NNS
of/IN
bone/NN
mineral/JJ
homeostasis/NN
,/,
bone/NN
remodeling/NN
and/CC
bone/NN
matrix/NN
composition/NN
./.
====================
These/DT
approach/DT
were/VBD
practically/RB
performed/VBN
by/IN
restriction/NN
fragment/NN
length/NN
polymorphisms/NNS
(/(
RFLPs/NNS
)/)
on/IN
various/JJ
populations/NNS
:/:
Caucasians/NNS
(/(
Deng/NNP
et/FW
al./FW
,/,
1999/CD
;/:
Langdahl/NNP
et/FW
al./FW
,/,
2000/CD
;/:
Quesada/NNP
et/FW
al./FW
,/,
2004/CD
)/)
,/,
AfricanAmericans/JJ
(/(
Zmuda/NNP
et/FW
al./FW
,/,
1999/CD
;/:
Harris/NNP
et/FW
al./FW
,/,
1997/CD
)/)
,/,
MexicanAmericans/NNP
(/(
Kammerer/NNP
et/FW
al./FW
,/,
2004/CD
;/:
McClure/NNP
et/FW
al./FW
,/,
1997/CD
)/)
,/,
and/CC
Asians/NNS
(/(
Mitra/NNP
et/FW
al./FW
,/,
2006/CD
;/:
Morita/NNP
et/FW
al./FW
,/,
2004/CD
;/:
Yamada/NNP
et/FW
al./FW
,/,
2003/CD
;/:
Zhang/NNP
et/FW
al./FW
,/,
2004/CD
)/)
./.
====================
Ethnicity/NN
was/VBD
shown/VBN
to/TO
be/VB
one/CD
of/IN
the/DT
important/JJ
factors/NNS
affecting/VBG
BMD/NN
(/(
Liel/JJ
et/FW
al./FW
,/,
1988/CD
;/:
Wang/NNP
et/FW
al./FW
,/,
1997/CD
)/)
./.
====================
However/RB
,/,
controversial/JJ
results/VBZ
of/IN
interethnic/JJ
differences/NNS
in/IN
allele/NN
or/CC
genotype/JJ
distributions/NNS
for/IN
BMD/NN
variation/NN
have/VBP
been/VBN
evidently/RB
presented/VBN
,/,
and/CC
a/DT
con/NN
sensus/NN
on/IN
the/DT
association/NN
with/IN
BMD/NN
on/IN
known/VBN
candidate/NN
genes/NNS
locus/NN
has/VBZ
not/RB
been/VBN
reached/VBN
yet/RB
(/(
Gamero/NNP
et/FW
al./FW
,/,
1995/CD
;/:
Peacock/NN
,/,
1995/CD
)/)
./.
====================
In/IN
this/DT
study/NN
,/,
we/PRP
have/VBP
analyzed/VBN
the/DT
statistical/JJ
association/NN
of/IN
Vitamin/NN
D/NN
receptor/NN
(/(
VDR/NN
)/)
gene/NN
polymorphisms/NNS
with/IN
intermediate/JJ
phenotypes/NNS
(/(
BMD/NN
;/:
major/JJ
risk/NN
factor/NN
of/IN
osteoporotic/JJ
fracture/NN
)/)
and/CC
fracture/NN
(/(
Fx/NNP
)/)
to/TO
address/VB
confounding/VBG
differences/NNS
in/IN
ethnic/JJ
backgrounds/NNS
involving/VBG
sample/JJ
size/NN
and/CC
stochastic/JJ
variability/NN
./.
====================
We/PRP
also/RB
performed/VBN
an/DT
analysis/NN
of/IN
haplotypes/NNS
in/IN
order/NN
to/TO
identify/VB
interaction/NN
of/IN
haplogenotypes/NNS
related/JJ
with/IN
osteoporosis/NN
./.
====================
The/DT
study/NN
population/NN
was/VBD
composed/VBN
of/IN
apparently/RB
healthy/JJ
postmenopausal/JJ
Korean/JJ
women/NNS
(/(
n=729/CD
)/)
who/WP
visited/VBD
the/DT
Asan/NN
Medical/JJ
Center/NN
(/(
AMC/NN
)/)
in/IN
Seoul/JJ
,/,
Korea/NN
./.
====================
Menopause/DT
was/VBD
defined/VBN
as/IN
the/DT
absence/NN
of/IN
menstruation/NN
for/IN
at/IN
least/JJS
6/CD
months/NNS
and/CC
was/VBD
confirmed/VBN
by/IN
measurement/NN
of/IN
serum/NN
follicle-stimulating/VBG
hormone/NN
levels/NNS
./.
====================
Women/NNS
who/WP
were/VBD
prematurely/RB
menopausal/JJ
(/(
aged＜40/NN
years/NNS
)/)
were/VBD
excluded/VBN
./.
====================
Those/DT
who/WP
had/VBD
taken/VBN
drugs/NNS
that/WDT
might/MD
affect/VB
bone/NN
metabolism/NN
for/IN
＞6/CD
months/NNS
,/,
or/CC
within/IN
the/DT
previous/JJ
12/CD
months/NNS
,/,
were/VBD
also/RB
excluded/VBN
./.
====================
Additionally/RB
,/,
women/NNS
were/VBD
excluded/VBN
if/IN
they/PRP
had/VBD
any/DT
disease/NN
that/DT
might/MD
affect/VB
bone/NN
metabolism/NN
./.
====================
The/DT
mean/JJ
age/NN
was/VBD
58.7±7.5/CD
years/NNS
and/CC
the/DT
mean/JJ
number/NN
of/IN
YSM/NN
was/VBD
9.4/CD
±7.8/CD
(/(
range/NN
1∼35/CD
)/)
years/NNS
./.
====================
Areal/JJ
BMD/NN
(/(
g/cm2/NN
)/)
at/IN
the/DT
lumbar/JJ
spine/NN
(/(
L2L4/NN
)/)
and/CC
femoral/JJ
neck/NN
was/VBD
measured/VBN
using/VBG
dual-energy/JJ
Xray/NN
absorptiometry/NN
(/(
Lunar/JJ
equipment/JJ
,/,
Expert/NN
XL/NN
,/,
Madison/NN
,/,
WIS/NN
)/)
in/IN
476/CD
women/NNS
./.
====================
In/IN
the/DT
other/JJ
253/CD
women/NNS
,/,
BMD/NN
was/VBD
measured/VBN
using/VBG
Hologic/JJ
equipment/JJ
(/(
Hologic/JJ
,/,
QDR/NN
4500-A/NN
,/,
Waltham/NN
,/,
MA/NN
)/)
./.
====================
The/DT
precisions/NNS
of/IN
the/DT
Lunar/JJ
and/CC
Hologic/JJ
equipment/JJ
,/,
presented/VBN
as/IN
coefficient/JJ
of/IN
variations/NNS
,/,
were/VBD
0.82/CD
%/NN
and/CC
0.85/CD
%/NN
for/IN
the/DT
lumbar/JJ
spine/NN
and/CC
1.12/CD
%/NN
and/CC
1.20/CD
%/NN
for/IN
the/DT
femoral/JJ
neck/NN
,/,
respectively/RB
./.
====================
These/DT
values/NNS
were/VBD
obtained/VBN
by/IN
scanning/VBG
17/CD
volunteers/NNS
who/WP
were/VBD
not/RB
part/NN
of/IN
the/DT
study/NN
;/:
each/DT
volunteer/NN
underwent/JJ
five/CD
scans/NNS
on/IN
the/DT
same/JJ
day/NN
,/,
getting/VBG
on/IN
and/CC
off/IN
the/DT
table/JJ
between/IN
examinations/NNS
./.
====================
To/TO
derive/VB
crosscalibration/NN
equations/NNS
between/IN
the/DT
two/CD
systems/NNS
,/,
BMD/NNP
values/NNS
were/VBD
measured/VBN
by/IN
the/DT
two/CD
machines/NNS
in/IN
109/CD
healthy/JJ
Korean/JJ
women/NNS
(/(
mean/JJ
age/NN
55±11/CD
,/,
range/NN
31∼75/CD
years/NNS
)/)
,/,
and/CC
cross-calibration/NN
equations/NNS
were/VBD
calculated/VBN
as/IN
follows/VBZ
(/(
Oldroyd/NNP
et/FW
al./FW
,/,
2003/CD
)/)
:/:
L2-L4/NN
BMD/NN
(/(
g/cm2/NN
)/)
:/:
Lunar/JJ
=/JJ
1.1287×Hologic−0.0027/CD
Femoral/JJ
neck/NN
BMD/NN
(/(
g/cm2/NN
)/)
:/:
Lunar=1.1556×Hologic−0.0182/NN
We/PRP
also/RB
obtained/VBN
BMD/NN
values/NNS
at/IN
other/JJ
proximal/JJ
femoral/JJ
sites/NNS
,/,
all/DT
taken/VBN
after/IN
January/JJ
2001/CD
./.
====================
The/DT
Hologic/JJ
machine/NN
did/VBD
not/RB
measure/VB
BMD/NN
at/IN
the/DT
femoral/JJ
shaft/NN
./.
====================
BMD/NN
values/NNS
at/IN
the/DT
femoral/JJ
shaft/NN
and/CC
at/IN
other/JJ
proximal/JJ
femur/JJ
sites/NNS
(/(
trochanter/NN
,/,
total/JJ
femur/NN
,/,
Ward/NN
’/CD
s/NNS
triangle/NN
)/)
were/VBD
available/JJ
for/IN
228/CD
and/CC
319/CD
participants/NNS
,/,
respectively/RB
./.
====================
Associations/NNS
between/IN
these/DT
BMD/NN
values/NNS
and/CC
VDR/NN
genetic/JJ
variations/NNS
were/VBD
determined/VBN
using/VBG
statistical/JJ
adjustments/NNS
with/IN
the/DT
machine/NN
as/IN
a/DT
covariate/JJ
,/,
because/IN
the/DT
crosscalibration/NN
data/NNS
are/VBP
not/RB
yet/RB
available/JJ
for/IN
Korean/JJ
women/NNS
at/IN
these/DT
sites/NNS
./.
====================
We/PRP
sequenced/VBD
all/DT
VDR/NN
exons/NNS
,/,
including/VBG
exonintron/NN
boundaries/NNS
,/,
and/CC
the/DT
promoter/NN
region/NN
(/(
ca/NN
./.
====================
1.5/CD
kb/NN
)/)
,/,
to/TO
detect/VB
SNPs/NNS
./.
====================
We/PRP
sequenced/VBD
24/CD
Korean/NN
DNA/NN
samples/NNS
using/VBG
the/DT
ABI/NN
PRISM/NN
3730/CD
DNA/NN
analyzer/NN
(/(
Applied/VBN
Biosystems/NNS
,/,
Foster/NN
City/NN
,/,
CA/NN
)/)
./.
====================
Sixteen/CD
primer/NN
sets/NNS
for/IN
amplification/NN
and/CC
sequencing/NN
analyses/NNS
were/VBD
designed/VBN
based/VBN
on/IN
GenBank/NN
sequences/NNS
(/(
Ref/NN
./.
====================
Seq/NN
./.
====================
of/IN
VDR/NN
mRNA/NN
:/:
NM_001017535.1/NN
,/,
and/CC
contig/NN
:/:
NT_029419.11/NN
)/)
./.
====================
Sequence/NN
variants/NNS
were/VBD
verified/VBN
by/IN
automated/JJ
sequencing/NN
chromatograms/NNS
./.
====================
SNPs/NNS
were/VBD
detected/VBN
by/IN
multiple/JJ
alignments/NNS
of/IN
sequences/NNS
using/VBG
the/DT
Phred/Phrap/Consed/JJ
package/NN
and/CC
polyphred/JJ
(/(
Ewing/JJ
et/FW
al./FW
,/,
1998/CD
;/:
Gordon/NN
et/FW
al./FW
,/,
1998/CD
;/:
Nickerson/NN
et/FW
al./FW
,/,
1997/CD
)/)
./.
====================
Genotyping/VBG
was/VBD
performed/VBN
at/IN
a/DT
multiplex/JJ
level/NN
using/VBG
the/DT
Illumina/NN
Golden/NNP
Gate/NN
genotyping/VBG
system/NN
(/(
Oilphant/JJ
et/FW
al./FW
,/,
2002/CD
)/)
,/,
and/CC
data/NNS
quality/NN
was/VBD
assessed/VBN
using/VBG
duplicate/JJ
DNAs/NNS
(/(
n=10/CD
)/)
./.
====================
The/DT
genotype/NN
quality/NN
score/NN
for/IN
data/NNS
retention/NN
was/VBD
set/NN
at/IN
0.25/CD
./.
====================
SNPs/NNS
that/DT
could/MD
not/RB
satisfy/JJ
the/DT
following/VBG
criteria/NNS
were/VBD
excluded/VBN
:/:
(/(
i/LS
)/)
a/DT
minimum/JJ
call/JJ
rate/NN
of/IN
90/CD
%/NN
;/:
(/(
ii/LS
)/)
no/DT
duplicate/JJ
error/NN
;/:
(/(
iii/LS
)/)
HardyWeinberg/JJ
equilibrium/NN
greater/JJR
than/IN
p＞0.001/NN
./.
====================
The/DT
χ2/NN
test/NN
was/VBD
used/VBN
to/TO
determine/VB
whether/IN
individual/JJ
variants/NNS
were/VBD
in/IN
equilibrium/NN
at/IN
each/DT
locus/NN
in/IN
the/DT
population/NN
(/(
HardyWeinberg/JJ
equilibrium/NN
)/)
./.
====================
We/PRP
examined/VBD
Lewontin/NN
’/CD
s/NNS
D/NN
'/``
(/(
|D'|/LS
)/)
,/,
and/CC
the/DT
linkage/NN
disequilibrium/NN
(/(
LD/NN
)/)
coefficient/JJ
γ2/NN
,/,
between/IN
all/DT
pairs/NNS
of/IN
biallelic/JJ
loci/NNS
./.
====================
Genotypes/NNS
were/VBD
given/VBN
codes/VBZ
of/IN
0/CD
,/,
1/CD
,/,
and/CC
2/CD
for/IN
the/DT
additive/JJ
model/NN
;/:
0/CD
,/,
1/CD
,/,
and/CC
1/CD
for/IN
the/DT
dominant/JJ
model/NN
;/:
and/CC
0/CD
,/,
0/CD
,/,
and/CC
1/CD
for/IN
the/DT
recessive/JJ
model/NN
./.
====================
Multiple/JJ
regression/NN
analyses/NNS
of/IN
BMD/NN
at/IN
the/DT
lumbar/JJ
spine/NN
and/CC
femoral/JJ
neck/NN
were/VBD
performed/VBN
using/VBG
age/NN
,/,
YSM/NN
,/,
weight/NN
,/,
and/CC
height/RB
,/,
as/IN
covariates/VBZ
./.
====================
Associations/NNS
of/IN
BMD/NN
values/NNS
at/IN
other/JJ
proximal/JJ
femur/JJ
sites/NNS
,/,
such/JJ
as/IN
the/DT
total/JJ
femur/JJ
,/,
the/DT
trochanter/NN
,/,
Ward/NNP
’/NNP
s/NNS
triangle/JJ
,/,
and/CC
the/DT
shaft/JJ
,/,
with/IN
VDR/NN
genotypes/NNS
,/,
were/VBD
determined/VBN
after/IN
further/JJ
statistical/JJ
adjustments/NNS
made/VBD
necessary/JJ
by/IN
the/DT
choice/NN
of/IN
bone/NN
densitometer/NN
,/,
because/IN
cross-calibration/NN
data/NNS
are/VBP
not/RB
available/JJ
,/,
to/TO
date/NN
,/,
for/IN
these/DT
values/NNS
in/IN
Korean/JJ
women/NNS
./.
====================
The/DT
genotype/NN
distributions/NNS
between/IN
participants/NNS
with/IN
or/CC
without/IN
fracture/NN
were/VBD
analyzed/VBN
using/VBG
a/DT
logistic/JJ
regression/NN
model/NN
controlling/VBG
for/IN
age/NN
,/,
YSM/NN
,/,
weight/NN
,/,
and/CC
height/RB
./.
====================
To/TO
investigate/VB
the/DT
genetic/JJ
effects/NNS
of/IN
VDR/NN
variants/NNS
on/IN
BMD/NN
and/CC
osteoporosis/NN
,/,
we/PRP
sequenced/VBD
all/DT
the/DT
VDR/NN
exons/NNS
and/CC
their/PRP$
boundaries/NNS
including/VBG
1.5/CD
kb/NN
of/IN
the/DT
5/CD
’/NN
flanking/JJ
region/NN
and/CC
identified/VBD
eighteen/CD
polymorphisms/NNS
three/CD
were/VBD
located/JJ
in/IN
the/DT
promoter/NN
,/,
three/CD
in/IN
coding/VBG
regions/NNS
of/IN
exons/NNS
(/(
two/CD
synonymous/JJ
and/CC
one/CD
nonsyn/JJ
./.
====================
)/)
,/,
nine/CD
in/IN
the/DT
3/CD
’/NN
untranslated/JJ
regions/NNS
(/(
UTRs/NNS
)/)
,/,
and/CC
three/CD
in/IN
the/DT
introns/NNS
./.
====================
We/PRP
genotyped/VBD
the/DT
eight/CD
selected/VBN
SNPs/NNS
for/IN
association/NN
studies/NNS
in/IN
postmenopausal/JJ
women/NNS
(/(
n=729/CD
)/)
./.
====================
Clinical/JJ
profiles/NNS
and/CC
the/DT
correlations/NNS
between/IN
BMD/NN
and/CC
age/NN
,/,
weight/NN
,/,
height/RB
,/,
and/CC
years/NNS
since/IN
menopause/NN
(/(
YSM/NN
)/)
are/VBP
listed/VBN
in/IN
Table/JJ
1/CD
./.
====================
The/DT
mean/JJ
age/NN
of/IN
the/DT
participants/NNS
was/VBD
58.7±7.5/CD
years/NNS
(/(
range/NN
43∼82/CD
years/NNS
)/)
,/,
and/CC
the/DT
mean/JJ
YSM/NN
was/VBD
9.5±7.8/CD
years/NNS
(/(
range/NN
1∼32/CD
years/NNS
)/)
./.
====================
As/IN
expected/VBN
,/,
age/NN
and/CC
YSM/NN
correlated/VBD
negatively/RB
with/IN
BMD/NN
at/IN
both/CC
the/DT
lumbar/JJ
spine/NN
and/CC
femoral/JJ
neck/NN
./.
====================
Weight/PRP
and/CC
height/NN
correlated/VBD
positively/RB
with/IN
BMD/NN
at/IN
both/CC
sites/NNS
./.
====================
In/IN
these/DT
participants/NNS
,/,
the/DT
genotype/NN
frequency/NN
of/IN
each/DT
of/IN
the/DT
eight/CD
SNPs/NNS
studied/VBN
is/VBZ
shown/VBN
in/IN
Table/JJ
2/CD
;/:
genotype/NN
distributions/NNS
were/VBD
in/IN
Hardy-Weinberg/JJ
equilibrium/NN
(/(
p＞/NN
0.001/CD
)/)
./.
====================
The/DT
VDR/NN
−5402G＞A/NN
,/,
−4926A＞G/NN
,/,
−4257G＞A/NN
,/,
−3949C＞T/NN
and/CC
＋34169C＞T/NN
SNPs/NNS
were/VBD
extremely/RB
rare/JJ
or/CC
monomorphic/JJ
in/IN
our/PRP$
subjects/NNS
./.
====================
Four/CD
common/JJ
haplotypes/NNS
(/(
freq/JJ
./.
====================
＞0.05/CD
)/)
in/IN
LD/NN
block/VBP
accounted/VBN
for/IN
43.0/CD
%/NN
(/(
ht-1/NN
)/)
,/,
29.0/CD
%/NN
(/(
ht-2/NN
)/)
,/,
21.9/CD
%/NN
(/(
ht-3/NN
)/)
and/CC
5.3/CD
%/NN
(/(
ht4/NN
)/)
of/IN
the/DT
distribution/NN
,/,
and/CC
were/VBD
used/VBN
for/IN
further/JJ
analysis/NN
(/(
Fig/NN
./.
====================
1/CD
)/)
./.
====================
We/PRP
found/VBD
that/IN
−4817G＞A/NN
was/VBD
significantly/RB
associated/VBN
with/IN
the/DT
risk/NN
of/IN
all/DT
fracture/NN
(/(
p=0.035/NN
)/)
./.
====================
The/DT
minor/JJ
allele/NN
(/(
A/DT
)/)
of/IN
−4817G＞A/NN
in/IN
intron/NN
region/NN
showed/VBD
susceptibility/NN
to/TO
the/DT
risk/NN
of/IN
fracture/NN
in/IN
the/DT
recessive/JJ
(/(
p=/JJ
0.035/CD
,/,
OR=0.2/CD
,/,
95/CD
%/NN
CI=0.05∼0.89/NN
)/)
./.
====================
Consistent/JJ
with/IN
fracture/NN
result/NN
,/,
VDR-ht3/NN
(/(
TCAA/NN
)/)
(/(
Fig/NN
./.
====================
1B/NN
)/)
comprising/VBG
risk/NN
allele/NN
also/RB
showed/VBD
the/DT
evidence/NN
of/IN
association/NN
with/IN
fracture/NN
risk/NN
by/IN
protective/JJ
effect/NN
(/(
p=0.05/NN
,/,
OR=0.23/NN
,/,
95/CD
%/NN
CI/NN
=0.05-1/NN
)/)
,/,
although/IN
the/DT
statistical/JJ
significance/NN
was/VBD
marginal/JJ
(/(
Table/JJ
3/CD
)/)
./.
====================
In/IN
logistic/JJ
regression/NN
analysis/NN
adjusted/VBD
for/IN
confounding/VBG
variables/NNS
,/,
we/PRP
found/VBD
that/IN
the/DT
VDR/NN
−4817G＞A/NN
and/CC
VDRht3/NN
were/VBD
significantly/RB
associated/VBN
with/IN
the/DT
BMD/NN
of/IN
various/JJ
proximal/JJ
femur/JJ
sites/NNS
as/IN
well/RB
as/IN
femoral/JJ
neck/NN
./.
====================
VDR/NN
−4817G＞A/NN
(/(
rs17882443/NN
)/)
showed/VBD
a/DT
significant/JJ
association/NN
with/IN
BMD/NN
at/IN
the/DT
femoral/JJ
neck/NN
(/(
p=0.017/CD
and/CC
0.019/CD
)/)
,/,
trochanter/RB
(/(
p=0.035/CD
and/CC
0.014/CD
)/)
,/,
shaft/RB
(/(
p=0.012/NN
and/CC
0.020/CD
)/)
,/,
and/CC
total/JJ
femur/JJ
(/(
p=0.030/CD
and/CC
0.016/CD
)/)
in/IN
the/DT
additive/JJ
and/CC
dominant/JJ
models/NNS
,/,
respectively/RB
(/(
Table/JJ
4/CD
)/)
./.
====================
In/IN
addition/NN
,/,
−5591T＞C/NN
in/IN
LD/NN
block/VBP
was/VBD
also/RB
associated/VBN
with/IN
higher/JJR
BMD/NN
of/IN
femoral/JJ
neck/NN
(/(
padditive=0.031/NN
)/)
and/CC
shaft/NN
(/(
padditive=0.021/NN
and/CC
pdominant=0.018/NN
)/)
,/,
respectively/RB
(/(
data/NNS
not/RB
shown/VBN
)/)
./.
====================
VDRht3/NN
was/VBD
associated/VBN
with/IN
increased/VBN
BMD/NN
values/NNS
of/IN
the/DT
femoral/JJ
neck/NN
(/(
padditive=0.028/NN
and/CC
pdominant=0.034/NN
)/)
,/,
trochanter/NN
(/(
padditive=0.042/NN
and/CC
pdominant=0.017/NN
)/)
,/,
shaft/RB
(/(
padditive=0.014/NN
,/,
pdominant=0.024/NN
and/CC
precessive=0.039/NN
)/)
,/,
and/CC
total/JJ
femur/NN
(/(
padditive=0.034/NN
and/CC
pdominant/JJ
=0.019/CD
)/)
,/,
respectively/RB
(/(
Table/JJ
4/CD
)/)
./.
====================
In/IN
the/DT
present/JJ
study/NN
,/,
we/PRP
closely/RB
examined/VBN
VDR/NN
gene/NN
region/NN
polymorphisms/NNS
for/IN
the/DT
association/NN
of/IN
the/DT
genetic/JJ
variations/NNS
with/IN
fracture/NN
risk/NN
and/CC
quantitative/JJ
traits/VBZ
(/(
BMD/NN
values/NNS
)/)
./.
====================
In/IN
this/DT
regard/NN
,/,
the/DT
VDR/NN
polymorphisms/NNS
are/VBP
expected/VBN
to/TO
provide/VB
more/RBR
extensive/JJ
genetic/JJ
information/NN
for/IN
osteoporosis/NN
or/CC
its/PRP$
related/JJ
fracture/NN
,/,
compared/VBN
with/IN
previous/JJ
standardized/VBD
testing/VBG
such/JJ
as/IN
RFLP/NN
based/VBN
on/IN
only/RB
four/CD
common/JJ
endonuclease/NN
,/,
ApaI/RB
(/(
rs17879735/NN
)/)
,/,
BsmI/NNP
(/(
1544410/CD
)/)
,/,
FokI/NNP
(/(
17881966/CD
)/)
,/,
and/CC
TaqI/NN
(/(
rs1788009/CD
)/)
./.
====================
VDR/NN
,/,
an/DT
intracellular/JJ
receptor/NN
that/WDT
specifically/RB
binds/VBZ
the/DT
active/JJ
form/NN
of/IN
vitamin/NN
D/NN
(/(
1,25-dihydroxyvitamin/NN
D3/NN
or/CC
calcitriol/NN
)/)
and/CC
interacts/VBZ
with/IN
targetcell/NN
nuclei/NNS
to/TO
produce/VB
a/DT
variety/NN
of/IN
biologic/JJ
effects/NNS
,/,
contains/VBZ
11/CD
exons/NNS
and/CC
spans/NNS
over/IN
41.2/CD
kb/NN
on/IN
chromosome/NN
12q13.11/NN
(/(
Baker/NN
et/FW
al./FW
,/,
1988/CD
)/)
./.
====================
When/WRB
haplotype/JJ
LD/NN
was/VBD
analyzed/VBN
based/VBN
on/IN
the/DT
individual/JJ
genotype/NN
information/NN
of/IN
selected/VBN
SNPs/NNS
,/,
VDR/NN
ht3/NN
was/VBD
significantly/RB
associated/VBN
with/IN
all/DT
fracture/NN
risk/NN
(/(
Table/JJ
3/CD
)/)
./.
====================
Among/IN
SNPs/NNS
of/IN
VDRht3/NN
,/,
the/DT
minor/JJ
allele/NN
of/IN
−4817G＞A/NN
was/VBD
also/RB
associated/VBN
with/IN
protective/JJ
effect/NN
of/IN
fracture/NN
./.
====================
Interestingly/RB
,/,
the/DT
effects/NNS
of/IN
VDR/NN
−4817G＞A/NN
on/IN
quantitative/JJ
BMD/NN
of/IN
the/DT
femoral/JJ
neck/NN
was/VBD
alleledose/DT
dependent/JJ
;/:
the/DT
highest/JJS
BMD/NN
being/VBG
found/VBN
in/IN
homozygotes/NNS
for/IN
the/DT
common/JJ
allele/NN
(/(
0.7±0.14/CD
)/)
,/,
intermediate/JJ
BMD/NN
in/IN
heterozygotes/NNS
(/(
0.68±0.12/CD
)/)
,/,
and/CC
the/DT
lowest/JJ
BMD/NN
in/IN
homozygotes/NNS
for/IN
the/DT
rare/JJ
allele/NN
(/(
0.67±/CD
0.11/CD
)/)
(/(
Table/JJ
4/CD
)/)
./.
====================
In/IN
addition/NN
,/,
both/CC
the/DT
−4817G＞A/NN
and/CC
VDR-ht3/NN
comprising/VBG
risk/NN
allele/NN
also/RB
showed/VBD
the/DT
evidence/NN
of/IN
association/NN
with/IN
higher/JJR
BMD/NN
values/NNS
of/IN
various/JJ
proximal/JJ
femur/JJ
sites/NNS
./.
====================
In/IN
our/PRP$
results/NNS
,/,
the/DT
VDR/NN
polymorphisms/NNS
are/VBP
associated/VBN
with/IN
higher/JJR
BMD/NN
of/IN
proximal/JJ
femur/JJ
sites/NNS
as/IN
well/RB
as/IN
femoral/JJ
neck/NN
,/,
but/CC
not/RB
with/IN
that/DT
of/IN
the/DT
lumbar/JJ
spine/NN
./.
====================
Since/IN
the/DT
femoral/JJ
shaft/NN
,/,
trochanter/NN
and/CC
total/JJ
femur/NN
have/VBP
higher/JJR
cortical/JJ
bone/NN
content/NN
that/DT
the/DT
lumbar/JJ
spine/NN
,/,
these/DT
polymorphisms/NNS
may/MD
influence/VB
cortical/JJ
bone/NN
strength/NN
./.
====================
Accordingly/RB
,/,
BMD/NN
values/NNS
at/IN
femur/JJ
neck/NN
predict/VBP
fractures/NNS
better/RBR
than/IN
those/DT
at/IN
vertebral/JJ
BMD/NN
./.
====================
Because/IN
the/DT
mean/JJ
age/NN
of/IN
our/PRP$
subjects/NNS
was/VBD
58.7/CD
years/NNS
,/,
these/DT
results/NNS
may/MD
have/VB
been/VBN
due/JJ
to/TO
osteoarthritis/NN
,/,
degenerative/JJ
changes/NNS
such/JJ
as/IN
bony/RB
spurs/VBZ
,/,
or/CC
aortic/JJ
calcification/NN
which/WDT
occur/VBP
more/RBR
often/RB
in/IN
the/DT
elderly/JJ
individuals/NNS
,/,
and/CC
therefore/RB
may/MD
have/VB
falsely/RB
changed/VBD
BMD/NN
measured/VBN
by/IN
dual/JJ
energy/NN
X-ray/NN
absorptiometry/NN
(/(
Burger/NNP
et/FW
al./FW
,/,
1996/CD
)/)
./.
====================
Although/IN
multiple/JJ
environmental/JJ
factors/NNS
are/VBP
involved/VBN
in/IN
the/DT
pathogenesis/NN
of/IN
osteoporosis/NN
,/,
genetic/JJ
factors/NNS
are/VBP
also/RB
largely/RB
responsible/JJ
for/IN
bone/NN
mass/NN
,/,
accounting/VBG
for/IN
about/RB
5085/CD
%/NN
of/IN
the/DT
variance/NN
in/IN
BMD/NN
on/IN
the/DT
basis/NN
of/IN
twin/JJ
and/CC
family/NN
studies/NNS
(/(
Arden/NN
and/CC
Spector/NN
,/,
1997/CD
;/:
Gueguen/NNP
et/FW
al./FW
,/,
1995/CD
;/:
Ng/NNP
et/FW
al./FW
,/,
2006/CD
)/)
./.
====================
However/RB
,/,
the/DT
heritability/NN
of/IN
fractures/NNS
has/VBZ
been/VBN
estimated/VBN
to/TO
lie/VB
only/RB
between/IN
25/CD
and/CC
35/CD
%/NN
(/(
Deng/NNP
et/FW
al./FW
,/,
2000/CD
;/:
MacGregor/NN
et/FW
al./FW
,/,
2000/CD
)/)
,/,
which/WDT
is/VBZ
much/RB
lower/JJR
than/IN
the/DT
heritability/NN
of/IN
BMD/NN
values/NNS
,/,
many/JJ
fallrelated/JJ
factors/NNS
other/JJ
than/IN
BMD/NN
must/MD
contribute/VB
to/TO
fracture/NN
risk/NN
./.
====================
The/DT
genetic/JJ
effects/NNS
of/IN
VDR/NN
polymorphisms/NNS
on/IN
BMD/NN
are/VBP
not/RB
dramatic/JJ
./.
====================
Because/IN
the/DT
associated/VBN
pvalues/NNS
did/VBD
not/RB
retain/VB
statistical/JJ
significance/NN
for/IN
multiple/JJ
comparisons/NNS
./.
====================
If/IN
Bonferroni/NNP
correction/NN
were/VBD
strictly/RB
adopted/JJ
,/,
associated/VBN
p-values/NNS
could/MD
not/RB
retain/VB
all/DT
significances/NNS
./.
====================
However/RB
,/,
although/IN
there/EX
is/VBZ
a/DT
chance/NN
of/IN
type/NN
I/CD
error/NN
due/JJ
to/TO
multiple/JJ
comparisons/NNS
,/,
when/WRB
considering/VBG
the/DT
facts/NNS
that/DT
consistent/JJ
positive/JJ
signals/NNS
at/IN
the/DT
same/JJ
sites/NNS
(/(
−4817G＞A/NN
and/CC
VDR-ht/NN
3/CD
)/)
with/IN
various/JJ
bone-related/JJ
phenotypes/NNS
,/,
the/DT
significance/NN
of/IN
associations/NNS
might/MD
be/VB
reasonable/JJ
./.
====================
Nevertheless/RB
,/,
it/PRP
might/MD
be/VB
worthwhile/JJ
to/TO
follow/VB
up/IN
on/IN
the/DT
effects/NNS
of/IN
this/DT
important/JJ
common/JJ
gene/NN
with/IN
larger/JJR
cohort/JJ
studies/NNS
,/,
considering/VBG
its/PRP$
vital/JJ
role/NN
in/IN
bone/NN
mineral/JJ
metabolism/NN
./.
====================
Further/RB
biological/JJ
and/CC
functional/JJ
evidence/NN
would/MD
be/VB
needed/VBN
to/TO
confirm/VB
the/DT
suggestive/JJ
association/NN
of/IN
VDR/NN
variants/NNS
with/IN
bone-related/JJ
phenotypes/NNS
./.
====================
After/IN
a/DT
multitude/JJ
of/IN
studies/NNS
,/,
several/JJ
standardized/VBD
variations/NNS
by/IN
RFLP/NN
have/VBP
been/VBN
investigated/VBN
for/IN
associations/NNS
with/IN
fracture/NN
and/CC
BMD/NN
,/,
but/CC
study/RB
results/VBZ
are/VBP
in/IN
consistent/JJ
(/(
Dvomyk/NN
et/FW
al./FW
,/,
2004/CD
;/:
Horst-Sikorska/NNP
et/FW
al./FW
,/,
2007/CD
;/:
Kiel/NNP
et/FW
al./FW
,/,
2007/CD
;/:
Long/JJ
et/FW
al./FW
,/,
2004/CD
;/:
Uitterlinden/NNP
et/FW
al./FW
,/,
2006/CD
)/)
./.
====================
have/VBP
performed/VBN
a/DT
large-scale/JJ
metaanalysis/NN
of/IN
studies/NNS
from/IN
prospective/JJ
multicenter/JJ
to/TO
investigate/VB
the/DT
effect/NN
on/IN
fracture/NN
incidence/NN
of/IN
four/CD
restrictionfragment-length/NN
polymorphisms/NNS
(/(
FokI/NN
,/,
BsmI/NNP
,/,
ApaI/RB
,/,
and/CC
TaqI/NN
)/)
./.
====================
These/DT
polymorphisms/NNS
were/VBD
not/RB
associated/VBN
with/IN
lumbar/JJ
spine/NN
or/CC
femoral/JJ
neck/NN
BMD/NN
./.
====================
However/RB
,/,
these/DT
results/NNS
are/VBP
inconsistent/JJ
with/IN
our/PRP$
investigations/NNS
carried/VBD
out/RP
for/IN
Korean/JJ
menopausal/JJ
women/NNS
./.
====================
This/DT
is/VBZ
probably/RB
due/JJ
to/TO
the/DT
fact/NN
that/IN
the/DT
study/NN
design/NN
did/VBD
not/RB
examine/VB
all/DT
VDR/NN
polymorphisms/NNS
,/,
contribute/VBP
more/RBR
to/TO
identify/VB
genetic/JJ
risk/NN
factors/NNS
./.
====================
Our/PRP$
results/NNS
suggest/VBP
that/IN
VDR/NN
polymorphisms/NNS
and/CC
haplotypes/NNS
provide/VBP
more/RBR
genetic/JJ
information/NN
on/IN
osteoporosis/NN
risk/NN
./.
====================
In/IN
conclusion/NN
,/,
we/PRP
identified/VBD
18/CD
polymorphisms/NNS
of/IN
VDR/NN
in/IN
Korean/JJ
population/NN
,/,
found/VBN
that/IN
−4817G＞A/NN
(/(
rs17882443/NN
)/)
and/CC
VDRht3/NN
were/VBD
significantly/RB
associated/VBN
with/IN
enhanced/VBN
BMD/NN
and/CC
fracture/NN
risk/NN
protection/NN
as/IN
genetic/JJ
factor/NN
./.
====================
Our/PRP$
observations/NNS
suggest/VBP
that/IN
these/DT
sequence/NN
based/VBN
variants/NNS
are/VBP
candidates/NNS
for/IN
genetic/JJ
determinants/NNS
of/IN
BMD/NN
of/IN
the/DT
hip/NN
in/IN
postmenopausal/JJ
women/NNS
./.
====================
